The effectiveness of the SMArT Work & Life intervention for reducing sitting time in office workers

Not Applicable

Completed

• Conditions: General chronic disease prevention; Not Applicable

• Registration Number: ISRCTN11618007
• Lead Sponsor: niversity of Leicester

Brief Summary

2018 Protocol article in https://pubmed.ncbi.nlm.nih.gov/30217233/ (added 04/03/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35977732/ (added 05/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36429578/ Cost-effectiveness (added 28/06/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38037043/ secondary process evaluation measures (added 05/12/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38115044/ intervention effectiveness (added 08/01/2024)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-01-24
• Study Completion: 2021-03-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 756

Inclusion Criteria

1. Office-based employees within the Councils in Leicester, Manchester and Liverpool areas (UK) (Liverpool added on 20/03/2019)
2. Spend the majority of their day sitting
3. They must also work for the council at least 3 days/week
4. Participant is willing and able to give informed consent to take part in the study
5. Able to walk without the use of an assistive device or requiring assistance form another person

Exclusion Criteria

1. Currently pregnant
2. Currently using a height-adjustable workstation at their primary work location
3. Unable to communicate in English
4. Unable to provide written informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 21/09/2020:<br>Objectively measured daily sitting time, measured using activPAL at 12 months<br><br>Previous primary outcome measure as of 02/08/2018:<br>Objectively measured daily sitting time, measured using activPAL at 24 months<br><br>Previous primary outcome measure:<br>Objectively measured sitting time, measured using activPAL at baseline, 3, 12, and 24 months